162 related articles for article (PubMed ID: 26974996)
1. An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.
Köbel M; Rahimi K; Rambau PF; Naugler C; Le Page C; Meunier L; de Ladurantaye M; Lee S; Leung S; Goode EL; Ramus SJ; Carlson JW; Li X; Ewanowich CA; Kelemen LE; Vanderhyden B; Provencher D; Huntsman D; Lee CH; Gilks CB; Mes Masson AM
Int J Gynecol Pathol; 2016 Sep; 35(5):430-41. PubMed ID: 26974996
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.
Hunter FW; Wouters BG; Wilson WR
Br J Cancer; 2016 May; 114(10):1071-7. PubMed ID: 27070712
[TBL] [Abstract][Full Text] [Related]
3. BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.
Stamp JP; Gilks CB; Wesseling M; Eshragh S; Ceballos K; Anglesio MS; Kwon JS; Tone A; Huntsman DG; Carey MS
Int J Gynecol Cancer; 2016 Jun; 26(5):825-32. PubMed ID: 27051059
[TBL] [Abstract][Full Text] [Related]
4. Optimized p53 immunohistochemistry is an accurate predictor of
Köbel M; Piskorz AM; Lee S; Lui S; LePage C; Marass F; Rosenfeld N; Mes Masson AM; Brenton JD
J Pathol Clin Res; 2016 Oct; 2(4):247-258. PubMed ID: 27840695
[No Abstract] [Full Text] [Related]
5. Mixed and Ambiguous Endometrial Carcinomas: A Heterogenous Group of Tumors With Different Clinicopathologic and Molecular Genetic Features.
Espinosa I; D'Angelo E; Palacios J; Prat J
Am J Surg Pathol; 2016 Jul; 40(7):972-81. PubMed ID: 26975040
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
Köbel M; Luo L; Grevers X; Lee S; Brooks-Wilson A; Gilks CB; Le ND; Cook LS
Int J Gynecol Pathol; 2019 Jul; 38(4):353-362. PubMed ID: 29901523
[TBL] [Abstract][Full Text] [Related]
7. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
Assem H; Rambau PF; Lee S; Ogilvie T; Sienko A; Kelemen LE; Köbel M
Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296
[TBL] [Abstract][Full Text] [Related]
8. Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.
Rambau P; Kelemen LE; Steed H; Quan ML; Ghatage P; Köbel M
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264438
[TBL] [Abstract][Full Text] [Related]
9. Histotype classification of ovarian carcinoma: A comparison of approaches.
Peres LC; Cushing-Haugen KL; Anglesio M; Wicklund K; Bentley R; Berchuck A; Kelemen LE; Nazeran TM; Gilks CB; Harris HR; Huntsman DG; Schildkraut JM; Rossing MA; Köbel M; Doherty JA
Gynecol Oncol; 2018 Oct; 151(1):53-60. PubMed ID: 30121132
[TBL] [Abstract][Full Text] [Related]
10. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
Lisio MA; Fu L; Goyeneche A; Gao ZH; Telleria C
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813239
[TBL] [Abstract][Full Text] [Related]
11. Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and heterogeneity of ovarian cancer.
Kroeger PT; Drapkin R
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):26-34. PubMed ID: 27898521
[TBL] [Abstract][Full Text] [Related]
13. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.
Kurman RJ; Shih IeM
Am J Pathol; 2016 Apr; 186(4):733-47. PubMed ID: 27012190
[TBL] [Abstract][Full Text] [Related]
14. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
15. The molecular origin and taxonomy of mucinous ovarian carcinoma.
Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Anglesio MS; Au-Yeung G; Böhm M; Bowtell DDL; Brand A; Chenevix-Trench G; Christie M; Chiew YE; Churchman M; DeFazio A; Demeo R; Dudley R; Fairweather N; Fedele CG; Fereday S; Fox SB; Gilks CB; Gourley C; Hacker NF; Hadley AM; Hendley J; Ho GY; Hughes S; Hunstman DG; Hunter SM; Jobling TW; Kalli KR; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Mes-Masson AM; Mileshkin L; Provencher DM; Pyman J; Rahimi K; Rowley SM; Salazar C; Samimi G; Saunders H; Semple T; Sharma R; Sharpe AJ; Stephens AN; Thio N; Torres MC; Traficante N; Xing Z; Zethoven M; Antill YC; Scott CL; Campbell IG; Gorringe KL
Nat Commun; 2019 Sep; 10(1):3935. PubMed ID: 31477716
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
17. Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Parra-Herran C; Lerner-Ellis J; Xu B; Khalouei S; Bassiouny D; Cesari M; Ismiil N; Nofech-Mozes S
Mod Pathol; 2017 Dec; 30(12):1748-1759. PubMed ID: 28776572
[TBL] [Abstract][Full Text] [Related]
18. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G; Folkins AK; McKenney JK; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical diagnosis of human infectious diseases: a review.
Oumarou Hama H; Aboudharam G; Barbieri R; Lepidi H; Drancourt M
Diagn Pathol; 2022 Jan; 17(1):17. PubMed ID: 35094696
[TBL] [Abstract][Full Text] [Related]
20. Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis.
Luu TT
Front Oncol; 2021; 11():799025. PubMed ID: 34988027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]